皮下输注GLP-1、OXM和PYY对肥胖志愿者能量摄入和消耗的影响
本研究为单盲、随机、安慰剂对照交叉设计,肥胖志愿者接受GLP-1、OXM和PYY(GOP)或安慰剂皮下持续输注每天10.5小时。输注剂量成功模拟RYGB术后餐后激素水平,使食物摄入平均减少32%,对静息能量消耗无显著影响。结论认为GOP安全有效减少食物摄入,三重激素疗法可能是有用的抗肥胖工具。
要点
- GOP皮下输注模拟RYGB术后餐后激素水平,使食物摄入平均减少32%。
- GOP输注对静息能量消耗无显著影响。
- 作者认为三重激素疗法可能是有用的抗肥胖工具。
核心结论
- 首次显示急性持续皮下输注GOP模拟RYGB术后餐后激素水平,安全且有效减少食物摄入。
- 数据提示三重激素疗法可能是有用的抗肥胖工具。
研究设计与样本
- 单盲、随机、安慰剂对照交叉研究,肥胖志愿者随机接受GOP或安慰剂皮下持续输注每天10.5小时。
- 使用泵装置皮下输注,允许志愿者保持活动。
- 输注期间进行随意食物摄入研究,使用通风罩热量计测量能量消耗。
主要发现
- 使用4 pmol/kg/min GLP-1、4 pmol/kg/min OXM和0.4 pmol/kg/min PYY成功匹配RYGB术后餐后激素水平。
- 该剂量使食物摄入平均减少32%。
- 对静息能量消耗未观察到显著影响。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Roux-en-Y gastric bypass (RYGB) surgery is currently the most effective treatment of obesity, although limited by availability and operative risk. The gut hormones Glucagon-like peptide-1 (GLP-1), Peptide YY (PYY), and Oxyntomodulin (OXM) are elevated postprandially after RYGB, which has been postulated to contribute to its metabolic benefits. OBJECTIVE: We hypothesized that infusion of the three gut hormones to achieve levels similar to those encountered postprandially in RYGB patients might be effective in suppressing appetite. The aim of this study was to investigate the effect of a continuous infusion of GLP-1, OXM, and PYY (GOP) on energy intake and expenditure in obese volunteers. METHODS: Obese volunteers were randomized to receive an infusion of GOP or placebo in a single-blinded, randomized, placebo-controlled crossover study for 10.5 hours a day. This was delivered subcutaneously using a pump device, allowing volunteers to remain ambulatory. Ad libitum food intake studies were performed during the infusion, and energy expenditure was measured using a ventilated hood calorimeter. RESULTS: Postprandial levels of GLP-1, OXM, and PYY seen post RYGB were successfully matched using 4 pmol/kg/min, 4 pmol/kg/min, and 0.4 pmol/kg/min, respectively. This dose led to a mean reduction of 32% in food intake. No significant effects on resting energy expenditure were observed. CONCLUSION: This is, to our knowledge, the first time that an acute continuous subcutaneous infusion of GOP, replicating the postprandial levels observed after RYGB, is shown to be safe and effective in reducing food intake. This data suggests that triple hormone therapy might be a useful tool against obesity.
引用
- Tan T, Behary P, Tharakan G, et al. The Effect of a Subcutaneous Infusion of GLP-1, OXM, and PYY on Energy Intake and Expenditure in Obese Volunteers. J Clin Endocrinol Metab. 2017. PMID: 28379519. doi:10.1210/jc.2017-00469
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。